Post-approval studies (Phase 4)Study completedNCT00168662What this trial is testingNon-Specific Effects of Standard Titre Measles VaccinationWho this might be right forMeasles Bandim Health Project 7,800
Early research (Phase 1)Ended earlyNCT02919449What this trial is testingDose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With AtezolizumabWho this might be right forRecurrent Non-Small Cell Lung Cancer Vyriad, Inc. 2
Large-scale testing (Phase 3)Study completedNCT01346293What this trial is testingStudy of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeWho this might be right forTetanusDiphtheriaPertussis+2 more Sanofi Pasteur, a Sanofi Company 3,372
Not applicableUnknownNCT01779180What this trial is testingVitamin A Supplementation at Birth and Atopy in ChildhoodWho this might be right forAtopyAsthmaEczema+1 more Bandim Health Project 2,000
Large-scale testing (Phase 3)Study completedNCT00985166What this trial is testingProQuad in Healthy 4 to 6 Year Old Children (V221-014)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 801
Not applicableStudy completedNCT02058927What this trial is testingImmune Reconstitution to Measles Virus of HIV Infected Children in ZambiaWho this might be right forMeasles University of North Carolina, Chapel Hill 203
Post-approval studies (Phase 4)Study completedNCT00388440What this trial is testingAssess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.Who this might be right forRubellaMumpsMeasles GlaxoSmithKline 150
Early research (Phase 1)Study completedNCT04497298What this trial is testingClinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 VaccineWho this might be right forCOVID-19 Institut Pasteur 90
Post-approval studies (Phase 4)UnknownNCT01486355What this trial is testingAdditional Measles Vaccine at 4 Months of AgeWho this might be right forMeasles Infection Bandim Health Project
Early research (Phase 1)Study completedNCT01846091What this trial is testingViral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00384397What this trial is testing2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersWho this might be right forMeningococcal MeningitisMeaslesMumps+2 more Sanofi Pasteur, a Sanofi Company 1,128
Not applicableStudy completedNCT07373093What this trial is testingPredictors of Measles Vaccine Hesitancy in New York StateWho this might be right forMeasles Vaccination Albany Medical College 99
Early research (Phase 1)Study completedNCT00408590What this trial is testingRecombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Mayo Clinic 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07406360What this trial is testingA Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeWho this might be right forMeasles GlaxoSmithKline 1,209
Post-approval studies (Phase 4)Study completedNCT01847872What this trial is testingIPV Clinical Trial - The GambiaWho this might be right forPoliomyelitis London School of Hygiene and Tropical Medicine 1,504
Testing effectiveness (Phase 2)Ended earlyNCT00258726What this trial is testingImmune Responses to Two Dose Varivax +/- MMR-IIWho this might be right forMeaslesMumpsRubella+1 more National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableUnknownNCT05154097What this trial is testingImmunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)Who this might be right forMeasles Vaccine The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 190
Not applicableActive Not RecruitingNCT06153979What this trial is testingInvestigation of Immune Amnesia Following Measles Infection in Select African RegionsWho this might be right forMeasles Infection National Institute of Allergy and Infectious Diseases (NIAID) 256
Post-approval studies (Phase 4)Study completedNCT00244673What this trial is testingRandomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles VaccinationWho this might be right forMortalityHospitalizationAdverse Events Bandim Health Project 6,534
Post-approval studies (Phase 4)Enrolling By InvitationNCT04220671What this trial is testingMeasles Vaccination at Health System ContactsWho this might be right forMeasles VaccineHospital AdmissionMortality+1 more Bandim Health Project 5,400